NuVasive
NuVasive raises $200M Convertible Note at $3.5B valuation
NuVasive: Convertible Note Funding Round
NuVasive has successfully raised $200M in Convertible Note funding, reaching a valuation of $3.5B.
Company Overview
Minimally disruptive surgical products for spine
Funding Details
The Convertible Note round was led by TPG Capital, with participation from Goldman Sachs.
Company Information
- Headquarters: 7475 Lusk Boulevard, San Diego, CA 92121
- Founded: 1997
- Employees: 2800+
- Category: MedTech
Investment
NuVasive plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- TPG Capital: Verified investor in Convertible Note
- Goldman Sachs: Verified investor in Convertible Note
Company Info
Investors (2)
Share
Related Reports
Galvenize Therapeutics Raises $100M Series C to Transform MedTech
Galvenize Therapeutics has secured $100M Series C in funding to accelerate growth and innovation in the medtech sector. Medical device company developing pulsed electric field therapies for cardiac ablation and tumor treatment...
Reprieve Cardiovascular Raises $61M Series B to Transform MedTech
Reprieve Cardiovascular has secured $61M Series B in funding to accelerate growth and innovation in the medtech sector. Cardiovascular device company developing personalized heart failure therapies and monitoring solutions...
ViCentra Raises $85M Series D to Transform MedTech
ViCentra has secured $85M Series D in funding to accelerate growth and innovation in the medtech sector. Medical device company developing innovative insulin patch pumps for diabetes management...
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free